What is Everolimus 10 mg?
Everolimus 10 mg is a prescription medication developed by Natco Pharma Ltd., primarily used in oncology. It contains the active ingredient Everolimus, which belongs to a class of drugs called mTOR inhibitors. This medicine is widely prescribed in the treatment of various cancers, including breast, pancreatic, and lung cancer. It plays an essential role in managing advanced or metastatic forms of these diseases.
Available for patients in Canada, Everolimus 10 mg helps to slow cancer growth by targeting specific cellular pathways responsible for tumor progression. Its use requires careful medical supervision due to its potent mechanism and potential side effects. Understanding how Everolimus 10 mg functions is crucial for patients embarking on cancer treatment plans.
Uses of Everolimus 10 mg
- Treatment of advanced breast cancer
- Management of pancreatic neuroendocrine tumors
- Therapy for non-small cell lung cancer
How Everolimus 10 mg Works
Everolimus works by inhibiting the mammalian target of rapamycin (mTOR), a protein that helps regulate cell growth, proliferation, and survival. Cancer cells often exploit the mTOR pathway to multiply uncontrollably. By blocking this pathway, Everolimus 10 mg effectively slows down tumor growth and proliferation.
This targeted approach helps to restrain cancer progression while minimizing damage to normal cells, making it a valuable option in combination with other cancer therapies.
Benefits of Everolimus 10 mg
- Controls tumor growth effectively
- Improves progression-free survival in patients with specific cancers
- Targets cancer cells selectively
- Can be combined with other anticancer agents
- Helps manage advanced cancers resistant to other treatments
Dosage and Administration
Everolimus 10 mg is usually administered orally once daily, as prescribed by a healthcare professional. The exact dosage and treatment duration depend on the type and severity of cancer, patient health status, and response to therapy. Patients are advised to take it consistently at the same time each day, with or without food, to maintain steady drug levels.
It is important to follow medical instructions strictly and attend regular monitoring appointments to assess treatment progress and manage any side effects.
Who Should Use Everolimus 10 mg?
Everolimus 10 mg is suitable for patients diagnosed with breast cancer, pancreatic neuroendocrine tumors, or non-small cell lung cancer as part of their oncologist’s treatment plan. It is intended for adults with advanced or metastatic disease requiring targeted therapy.
Patients with adequate organ function and who can be monitored for side effects may benefit from this treatment under medical supervision.
Who Should Avoid Everolimus 10 mg?
Everolimus 10 mg should be avoided by individuals with known hypersensitivity to Everolimus or its ingredients. It is not recommended for pregnant or breastfeeding women due to potential risks to the fetus or infant.
Patients with severe liver impairment or active infections should consult their healthcare provider before starting Everolimus. It may also be unsuitable for individuals with compromised immune systems or those unable to attend regular medical follow-ups.
Side Effects
- Mouth sores or ulcers
- Fatigue or weakness
- Diarrhea
- Nausea
- Increased risk of infections
- Rash or skin irritation
- Swelling of hands, feet, or ankles
- Shortness of breath
- Elevated blood sugar levels
- Weight loss
Safety Advice
- Regularly monitor blood counts and organ function
- Avoid exposure to infections, and report symptoms promptly
- Do not stop the medication without consulting your doctor
- Inform healthcare providers about any other medications or supplements
- Maintain scheduled medical appointments for evaluation
- Use effective contraception during treatment and for some time after
- Report any allergic reactions immediately
Drug Interactions
- Cyclosporine
- Ketoconazole
- Rifampin
- Phenytoin
- St. John’s Wort
- Other immunosuppressive drugs
Storage Instructions
Store Everolimus 10 mg tablets at room temperature between 20°C to 25°C (68°F to 77°F). Keep the medication in its original container, tightly closed, and away from moisture and direct sunlight. Keep out of reach of children and pets. Do not use after the expiration date on the package.
Where to buy Everolimus 10 mg in Canada?
Patients looking to buy Everolimus 10 mg in Canada should obtain a valid prescription from a licensed healthcare professional. The medication is available through certified pharmacies and authorized online platforms with proper prescription verification. Purchasing from reliable sources ensures authenticity, safety, and proper storage of this critical oncology medicine.
Frequently Asked Questions (FAQ)
Is Everolimus 10 mg available in Canada?
Yes, Everolimus 10 mg is approved and available in Canada through licensed pharmacies with a valid prescription.
What is the price of Everolimus 10 mg in Canada?
The price varies depending on the pharmacy and insurance coverage. Patients should consult local pharmacies for current pricing and check eligibility for financial assistance programs.
What happens if I miss a dose?
If you miss a dose, take it as soon as you remember unless it is almost time for your next dose. Do not take a double dose to make up for a missed one. Consult your healthcare provider if unsure.
Where can I find Everolimus 10 mg for sale?
Everolimus 10 mg can be purchased at authorized pharmacies across Canada and through reputable online pharmacies that require a valid prescription.
Can Everolimus 10 mg be used during pregnancy?
No, Everolimus should not be used during pregnancy due to potential harm to the fetus. Women of childbearing potential should use effective contraception during treatment.
Are there specific dietary restrictions while on Everolimus 10 mg?
There are no strict dietary restrictions, but it is advisable to avoid grapefruit and grapefruit products as they may affect drug metabolism.
How should I prepare for my medical appointments while on Everolimus?
Keep track of any side effects, adhere to your dosing schedule, and bring a list of all medications and supplements to your physician for effective monitoring.
Conclusion
Everolimus 10 mg is a significant advancement in targeted cancer therapy, offering patients with advanced breast, pancreatic, and lung cancers an option that specifically inhibits tumor growth pathways. Manufactured by Natco Pharma Ltd., it combines efficacy with careful management of side effects. Patients in Canada considering Everolimus 10 mg should consult their oncologist to understand the benefits, risks, and proper administration of this medicine. With thorough medical supervision, Everolimus 10 mg can be a valuable component of a comprehensive cancer treatment plan.
Leave A Review